Abbott Laboratories (ABT)
USD 131.62
(1.33%)
USD 131.62
(1.33%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 34.38 Billion USD | -8.38% |
| 2022 | 37.53 Billion USD | -4.18% |
| 2021 | 39.17 Billion USD | -0.94% |
| 2020 | 39.54 Billion USD | 8.09% |
| 2019 | 36.58 Billion USD | 0.37% |
| 2018 | 36.45 Billion USD | -19.27% |
| 2017 | 45.15 Billion USD | 41.33% |
| 2016 | 31.94 Billion USD | 60.38% |
| 2015 | 19.92 Billion USD | 1.45% |
| 2014 | 19.63 Billion USD | 11.03% |
| 2013 | 17.68 Billion USD | -56.25% |
| 2012 | 40.42 Billion USD | 13.07% |
| 2011 | 35.75 Billion USD | -3.34% |
| 2010 | 36.98 Billion USD | 25.3% |
| 2009 | 29.51 Billion USD | 18.36% |
| 2008 | 24.93 Billion USD | 13.7% |
| 2007 | 21.93 Billion USD | -0.85% |
| 2006 | 22.12 Billion USD | 50.24% |
| 2005 | 14.72 Billion USD | 1.97% |
| 2004 | 14.44 Billion USD | 5.85% |
| 2003 | 13.64 Billion USD | 0.36% |
| 2002 | 13.59 Billion USD | -4.51% |
| 2001 | 14.23 Billion USD | 112.1% |
| 2000 | 6.71 Billion USD | -4.7% |
| 1999 | 7.04 Billion USD | -6.12% |
| 1998 | 7.5 Billion USD | 6.23% |
| 1997 | 7.06 Billion USD | 12.01% |
| 1996 | 6.3 Billion USD | 25.71% |
| 1995 | 5.01 Billion USD | 12.1% |
| 1994 | 4.47 Billion USD | 11.48% |
| 1993 | 4.01 Billion USD | 11.69% |
| 1992 | 3.59 Billion USD | 17.73% |
| 1991 | 3.05 Billion USD | 11.82% |
| 1990 | 2.72 Billion USD | 28.44% |
| 1989 | 2.12 Billion USD | -9.97% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | - USD | 2.6% |
| 2024 Q1 | 33.42 Billion USD | -2.8% |
| 2024 Q2 | 33.45 Billion USD | 0.1% |
| 2023 Q1 | 36.56 Billion USD | -2.59% |
| 2023 Q3 | 34.39 Billion USD | -4.32% |
| 2023 Q2 | 35.95 Billion USD | -1.67% |
| 2023 FY | 34.38 Billion USD | -8.38% |
| 2023 Q4 | 34.38 Billion USD | -0.03% |
| 2022 Q4 | 37.53 Billion USD | 1.67% |
| 2022 Q3 | 36.91 Billion USD | -1.52% |
| 2022 Q2 | 37.48 Billion USD | -2.32% |
| 2022 Q1 | 38.37 Billion USD | -2.03% |
| 2022 FY | 37.53 Billion USD | -4.18% |
| 2021 Q2 | 39.24 Billion USD | 0.62% |
| 2021 Q1 | 38.99 Billion USD | -1.39% |
| 2021 Q3 | 39.15 Billion USD | -0.21% |
| 2021 Q4 | 39.17 Billion USD | 0.04% |
| 2021 FY | 39.17 Billion USD | -0.94% |
| 2020 Q3 | 37.44 Billion USD | -1.4% |
| 2020 FY | 39.54 Billion USD | 8.09% |
| 2020 Q4 | 39.54 Billion USD | 5.6% |
| 2020 Q1 | 36.35 Billion USD | -0.65% |
| 2020 Q2 | 37.97 Billion USD | 4.48% |
| 2019 FY | 36.58 Billion USD | 0.37% |
| 2019 Q1 | 36.48 Billion USD | 0.08% |
| 2019 Q2 | 36.53 Billion USD | 0.14% |
| 2019 Q3 | 36.52 Billion USD | -0.04% |
| 2019 Q4 | 36.58 Billion USD | 0.18% |
| 2018 Q4 | 36.45 Billion USD | -10.53% |
| 2018 Q3 | 40.73 Billion USD | 8.23% |
| 2018 Q2 | 37.64 Billion USD | -4.24% |
| 2018 Q1 | 39.3 Billion USD | -12.95% |
| 2018 FY | 36.45 Billion USD | -19.27% |
| 2017 Q1 | 39.34 Billion USD | 23.13% |
| 2017 FY | 45.15 Billion USD | 41.33% |
| 2017 Q4 | 45.15 Billion USD | 12.8% |
| 2017 Q3 | 40.03 Billion USD | 1.69% |
| 2017 Q2 | 39.36 Billion USD | 0.06% |
| 2016 Q2 | 19.03 Billion USD | 1.28% |
| 2016 Q1 | 18.79 Billion USD | -5.65% |
| 2016 Q4 | 31.94 Billion USD | 71.76% |
| 2016 Q3 | 18.6 Billion USD | -2.29% |
| 2016 FY | 31.94 Billion USD | 60.38% |
| 2015 Q4 | 19.92 Billion USD | -2.85% |
| 2015 FY | 19.92 Billion USD | 1.45% |
| 2015 Q1 | 21.1 Billion USD | 7.49% |
| 2015 Q2 | 20.99 Billion USD | -0.51% |
| 2015 Q3 | 20.5 Billion USD | -2.35% |
| 2014 Q3 | 19.52 Billion USD | 9.85% |
| 2014 Q2 | 17.77 Billion USD | -2.21% |
| 2014 FY | 19.63 Billion USD | 11.03% |
| 2014 Q4 | 19.63 Billion USD | 0.59% |
| 2014 Q1 | 18.17 Billion USD | 2.75% |
| 2013 Q1 | 20 Billion USD | -50.51% |
| 2013 Q4 | 17.68 Billion USD | -13.07% |
| 2013 FY | 17.68 Billion USD | -56.25% |
| 2013 Q3 | 20.34 Billion USD | -0.64% |
| 2013 Q2 | 20.47 Billion USD | 2.36% |
| 2012 FY | 40.42 Billion USD | 13.07% |
| 2012 Q4 | 40.42 Billion USD | 11.81% |
| 2012 Q3 | 36.15 Billion USD | -3.04% |
| 2012 Q2 | 37.28 Billion USD | 1.13% |
| 2012 Q1 | 36.87 Billion USD | 3.14% |
| 2011 Q3 | 34.93 Billion USD | -1.68% |
| 2011 Q4 | 35.75 Billion USD | 2.32% |
| 2011 Q2 | 35.53 Billion USD | -3.78% |
| 2011 Q1 | 36.93 Billion USD | -0.15% |
| 2011 FY | 35.75 Billion USD | -3.34% |
| 2010 Q4 | 36.98 Billion USD | 3.05% |
| 2010 Q2 | 33.38 Billion USD | 3.22% |
| 2010 FY | 36.98 Billion USD | 25.3% |
| 2010 Q1 | 32.34 Billion USD | 9.58% |
| 2010 Q3 | 35.89 Billion USD | 7.5% |
| 2009 Q2 | 27.7 Billion USD | 0.93% |
| 2009 Q1 | 27.45 Billion USD | 10.08% |
| 2009 FY | 29.51 Billion USD | 18.36% |
| 2009 Q3 | 28.47 Billion USD | 2.75% |
| 2009 Q4 | 29.51 Billion USD | 3.67% |
| 2008 Q1 | 23.19 Billion USD | 5.76% |
| 2008 Q2 | 25.11 Billion USD | 8.26% |
| 2008 Q4 | 24.93 Billion USD | 11.3% |
| 2008 FY | 24.93 Billion USD | 13.7% |
| 2008 Q3 | 22.4 Billion USD | -10.78% |
| 2007 FY | 21.93 Billion USD | -0.85% |
| 2007 Q3 | 22.01 Billion USD | 0.89% |
| 2007 Q1 | 21.96 Billion USD | -0.71% |
| 2007 Q2 | 21.81 Billion USD | -0.67% |
| 2007 Q4 | 21.93 Billion USD | -0.36% |
| 2006 Q1 | 14.08 Billion USD | -4.32% |
| 2006 Q4 | 22.12 Billion USD | 25.23% |
| 2006 Q2 | 18.87 Billion USD | 33.97% |
| 2006 FY | 22.12 Billion USD | 50.24% |
| 2006 Q3 | 17.66 Billion USD | -6.41% |
| 2005 Q4 | 14.72 Billion USD | 1.08% |
| 2005 FY | 14.72 Billion USD | 1.97% |
| 2005 Q3 | 14.56 Billion USD | 8.43% |
| 2005 Q2 | 13.43 Billion USD | -8.48% |
| 2005 Q1 | 14.67 Billion USD | 1.65% |
| 2004 Q4 | 14.44 Billion USD | -1.14% |
| 2004 FY | 14.44 Billion USD | 5.85% |
| 2004 Q1 | 14.54 Billion USD | 6.58% |
| 2004 Q2 | 14.86 Billion USD | 2.19% |
| 2004 Q3 | 14.6 Billion USD | -1.69% |
| 2003 Q1 | 13.51 Billion USD | -0.61% |
| 2003 Q2 | 13.99 Billion USD | 3.6% |
| 2003 Q3 | 14.28 Billion USD | 2.09% |
| 2003 Q4 | 13.64 Billion USD | -4.53% |
| 2003 FY | 13.64 Billion USD | 0.36% |
| 2002 Q1 | 13.31 Billion USD | -6.44% |
| 2002 Q4 | 13.59 Billion USD | 3.67% |
| 2002 Q3 | 13.11 Billion USD | -0.39% |
| 2002 FY | 13.59 Billion USD | -4.51% |
| 2002 Q2 | 13.16 Billion USD | -1.17% |
| 2001 FY | 14.23 Billion USD | 112.1% |
| 2001 Q4 | 14.23 Billion USD | 1.34% |
| 2001 Q3 | 14.04 Billion USD | 3.57% |
| 2001 Q2 | 13.56 Billion USD | -2.27% |
| 2001 Q1 | 13.87 Billion USD | 106.77% |
| 2000 Q2 | 6.77 Billion USD | -4.34% |
| 2000 FY | 6.71 Billion USD | -4.7% |
| 2000 Q3 | 6.66 Billion USD | -1.67% |
| 2000 Q4 | 6.71 Billion USD | 0.69% |
| 2000 Q1 | 7.08 Billion USD | 0.62% |
| 1999 Q1 | 7.25 Billion USD | -3.3% |
| 1999 Q2 | 6.7 Billion USD | -7.57% |
| 1999 Q3 | 6.9 Billion USD | 2.96% |
| 1999 Q4 | 7.04 Billion USD | 2.01% |
| 1999 FY | 7.04 Billion USD | -6.12% |
| 1998 Q2 | 7.37 Billion USD | 5.75% |
| 1998 Q3 | 7.22 Billion USD | -1.97% |
| 1998 FY | 7.5 Billion USD | 6.23% |
| 1998 Q4 | 7.5 Billion USD | 3.78% |
| 1998 Q1 | 6.97 Billion USD | -1.26% |
| 1997 FY | 7.06 Billion USD | 12.01% |
| 1997 Q4 | 7.06 Billion USD | 4.88% |
| 1997 Q1 | 6.34 Billion USD | 0.62% |
| 1997 Q2 | 6.49 Billion USD | 2.4% |
| 1997 Q3 | 6.73 Billion USD | 3.65% |
| 1996 Q1 | 4.74 Billion USD | -5.37% |
| 1996 Q3 | 5.95 Billion USD | 0.71% |
| 1996 Q2 | 5.91 Billion USD | 24.59% |
| 1996 Q4 | 6.3 Billion USD | 5.88% |
| 1996 FY | 6.3 Billion USD | 25.71% |
| 1995 Q1 | 4.62 Billion USD | 3.28% |
| 1995 FY | 5.01 Billion USD | 12.1% |
| 1995 Q2 | 4.74 Billion USD | 2.73% |
| 1995 Q4 | 5.01 Billion USD | 4.63% |
| 1995 Q3 | 4.79 Billion USD | 0.98% |
| 1994 Q2 | 4.22 Billion USD | 5.78% |
| 1994 Q1 | 3.99 Billion USD | -0.45% |
| 1994 Q3 | 4.39 Billion USD | 4.04% |
| 1994 Q4 | 4.47 Billion USD | 1.74% |
| 1994 FY | 4.47 Billion USD | 11.48% |
| 1993 Q1 | 3.69 Billion USD | 2.86% |
| 1993 Q2 | 3.81 Billion USD | 3.1% |
| 1993 Q3 | 3.93 Billion USD | 3.34% |
| 1993 Q4 | 4.01 Billion USD | 1.91% |
| 1993 FY | 4.01 Billion USD | 11.69% |
| 1992 Q3 | 3.53 Billion USD | 11.97% |
| 1992 Q1 | 3.1 Billion USD | 1.78% |
| 1992 Q2 | 3.15 Billion USD | 1.69% |
| 1992 Q4 | 3.59 Billion USD | 1.59% |
| 1992 FY | 3.59 Billion USD | 17.73% |
| 1991 Q1 | 2.83 Billion USD | 3.89% |
| 1991 Q3 | 2.85 Billion USD | -0.19% |
| 1991 Q4 | 3.05 Billion USD | 6.84% |
| 1991 FY | 3.05 Billion USD | 11.82% |
| 1991 Q2 | 2.86 Billion USD | 0.93% |
| 1990 Q1 | 2.42 Billion USD | 14.21% |
| 1990 Q3 | 2.98 Billion USD | 11.6% |
| 1990 Q2 | 2.67 Billion USD | 10.11% |
| 1990 FY | 2.72 Billion USD | 28.44% |
| 1990 Q4 | 2.72 Billion USD | -8.48% |
| 1989 Q4 | 2.12 Billion USD | 0.0% |
| 1989 FY | 2.12 Billion USD | -9.97% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Allurion Technologies Inc. | 142.19 Million USD | -24082.308% |
| Artivion, Inc. | 510.61 Million USD | -6634.402% |
| Avanos Medical, Inc. | 456.1 Million USD | -7439.355% |
| Butterfly Network, Inc. | 84.22 Million USD | -40729.484% |
| Butterfly Network, Inc. | 84.22 Million USD | -40729.484% |
| Bio-Rad Laboratories, Inc. | 3.55 Billion USD | -866.487% |
| Boston Scientific Corporation | 15.6 Billion USD | -120.345% |
| CONMED Corporation | 1.46 Billion USD | -2245.956% |
| Edwards Lifesciences Corporation | 2.64 Billion USD | -1200.666% |
| Paragon 28, Inc. | 162.95 Million USD | -21001.756% |
| Glaukos Corporation | 478.64 Million USD | -7084.194% |
| Globus Medical, Inc. | 1.08 Billion USD | -3060.21% |
| Inspire Medical Systems, Inc. | 104.29 Million USD | -32870.268% |
| Integer Holdings Corporation | 1.41 Billion USD | -2333.232% |
| Medtronic plc | 39.56 Billion USD | 13.079% |
| Myomo, Inc. | 5.59 Million USD | -614808.074% |
| Nevro Corp. | 330.31 Million USD | -10310.492% |
| Owlet, Inc. | 73.79 Million USD | -46495.482% |
| Penumbra, Inc. | 377.36 Million USD | -9012.494% |
| Vicarious Surgical Inc. | 21.89 Million USD | -156954.122% |
| Smith & Nephew plc | 4.77 Billion USD | -620.901% |
| Sonendo, Inc. | 49.74 Million USD | -69032.104% |
| STERIS plc | 4.74 Billion USD | -624.188% |
| Stryker Corporation | 21.31 Billion USD | -61.297% |
| Vapotherm, Inc. | 132.95 Million USD | -25764.416% |
| Zimmer Biomet Holdings, Inc. | 9 Billion USD | -281.709% |